Halliburton EVP and COO Slocum sells $565,573 in stock

Jeffrey Shannon Slocum, Halliburton Co.'s Executive Vice President and Chief Operating Officer, divested 16,121 shares of the company's stock on August 18, 2026. The sale, totaling approximately $565,573, took place under a pre-established Rule 10b5-1 trading plan adopted on May 8, 2026. The shares were exchanged at a weighted average price of $35.083 per share, with individual transaction prices spanning from $35.00 to $35.255.

This move comes following a strong year for Halliburton shares, which have delivered a 68% return. As of the latest update, Halliburton shares are trading at $34.92. Post the transaction, Slocum directly owns 171,301.952 shares of Halliburton common stock. His portfolio also includes options to purchase additional shares, specifically 12,090 shares with an exercise price of $49.61, expiring on January 2, 2028, and 3,722 shares with an exercise price of $55.68, expiring on January 3, 2027.

Analysts have noted that Halliburton appears undervalued at current market levels. Investors seeking a comprehensive understanding of the company's prospects may refer to Halliburton's Pro Research Report, which provides in-depth analysis of the firm's financials and market position. Additionally, Halliburton recently reported its second-quarter 2026 earnings, which exceeded Wall Street's expectations.

The company reported adjusted earnings per share of $0.55 and revenue of $5.7 billion, surpassing the projected $0.54 per share on $5.5 billion in revenue. This performance marked a 6% sequential increase in revenue.

However, despite this strong quarterly performance, Halliburton's stock price has seen a decline. This dip was largely attributed to investors' focus on softer near-term guidance and prevailing regional uncertainties. International sales for the company reached their highest level in over a decade, totaling $3.4 billion, as growth in Europe, Africa, and Latin America bolstered the performance. Analyst reactions to these developments have been mixed.

Freedom Broker upgraded Halliburton's stock rating to Hold from Sell, raising the price target to $37 from $32, citing the earnings beat. On the other hand, UBS lowered its price target to $39 from $40 and maintained a Neutral rating, citing concerns about margin pressure and a third-quarter outlook that falls short of prior estimates. Similarly, TD Cowen reduced its price target to $47 from $48 while retaining a Buy rating, highlighting a margin miss and guidance that fell slightly below market consensus.

These recent events highlight the diverse perspectives among analysts regarding Halliburton's future outlook. This report was produced with the aid of AI technology and reviewed by a human editor.